Research Methodology – Rare Disease Diagnostics Market
At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Rare Disease Diagnostics Market comprises the following key stages:
Market Indicator & Macro-Factor Analysis
Our baseline thesis for the Rare Disease Diagnostics Market is developed by integrating key market indicators and macroeconomic variables. These include:
Factors considered while calculating market size and share
- Prevalence and incidence of rare diseases globally
- Number of diagnostic tests available and their market penetration
- Growth rate of the biomarker identification industry
- Investment in research and development for rare diseases
- Healthcare expenditure by region/country
- Government policies regarding rare disease diagnosis and treatment
- Reimbursement scenario for diagnostic tests
- Market presence of key players
Key Market Indicators
- Number of rare diseases identified and registered
- Number of specialized diagnostic centers or laboratories
- Number of approved diagnostic tests for rare diseases
- Research & Development expenditure by key players
- Regulatory approvals for new diagnostic products/services
- Patient pool and demographics
- Pricing trends and insurance coverage for rare disease diagnostics
Growth Trends
- Increasing investment in rare disease research
- Emerging biomarker-based diagnostics
- Increasing adoption of genomics and personalized medicine for rare disease diagnosis
- Increasing collaborations between industry players and research organizations
- Rising awareness about rare diseases and their diagnosis
- Technological advancements in diagnostic techniques
- Growth of telehealth and digital health platforms aiding in diagnostics
Secondary Research
Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Rare Disease Diagnostics Market. Key inputs include:
- Annual reports, investor presentations, SEC filings
- Company press releases and product launch announcements
- Public executive interviews and earnings calls
- Strategy briefings and M&A updates
- Country-level industry associations and trade bodies
- Government dossiers, policy frameworks, and official releases
- Whitepapers, working papers, and public R&D initiatives
- Relevant Associations for the Rare Disease Diagnostics Market
- Broker reports and financial analyst coverage
- Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
- Import/export trade data and tariff databases
- Sector-specific journals, magazines, and news portals
- Global macroeconomic indicators and their cascading effect on the industry
- Demand–supply outlook and value chain analysis
- Consumer behaviour, adoption rates, and commercialization trends
Primary Research
To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:
- Key Opinion Leader (KOL) Engagements
- Structured interviews with executives, product managers, and domain experts
- Paid and barter-based interviews across manufacturers, distributors, and end-users
- Discussions with stakeholders to validate demand-supply gaps
- Group discussions on emerging technologies, regulatory shifts, and adoption barriers
- Cross-verification of market sizing and forecasts with industry insiders
- Capturing business perspectives on growth opportunities and restraints
Data Triangulation & Forecasting
The final step of our research involves data triangulation ensuring accuracy through cross-verification of:
- Demand-side analysis (consumption patterns, adoption trends, customer spending)
- Supply-side analysis (production, capacity, distribution, and market availability)
- Macroeconomic & microeconomic impact factors
- Time-series analysis
- Regression and correlation studies
- Baseline modeling
- Expert validation at each stage
Outcome
The outcome is a comprehensive and validated market model that captures:
- Market sizing (historical, current, forecast)
- Growth drivers and restraints
- Opportunity mapping and investment hotspots
- Competitive positioning and strategic insights
Available for purchase with detailed segment data, forecasts, and regional insights.
Get This ReportOur Clients:
